The mint-flavoured chewable tablet formulation can be prescribed at NHS expense provided the patient meets the criteria set out for erectile dysfunction: it must only be prescribed for men who have:
- prostate cancer,
- kidney failure treated with dialysis or transplantation,
- spinal cord injury,
- multiple sclerosis,
- single gene neurological disease,
- spina bifida,
- Parkinson's disease,
- severe pelvic injury, or
- undergone previous radical pelvic surgery or prostatectomy.
It is also available for men who were already receiving drug treatment for impotence on the NHS on 14 September 1998, and through specialist services for men suffering severe distress because of impotence.
When prescribed in this way, the prescription must be marked 'SLS'.
Further information: Amdipharm Mercury